Another weapon against amyloid.
نویسنده
چکیده
A lzheimer’s disease (AD) is one of those conditions that, like cancer in earlier generations, inspires particular terror among the general public. Therapeutic advances have lagged behind insights into genetics and pathophysiology, and although -amyloid (A ), the product of amyloid precursor protein (APP) cleavage, remains the leading suspect among proposed pathogenic factors, its causal role in AD has not been established with certainty. At present, patients with AD have access to two approved specific treatments, acetylcholinesterase inhibitors and the glutamate receptor antagonist memantine, neither of which is dramatically effective. Several experimental approaches are also under study, including A vaccines, metal chelators, and derivatives of Congo red dye, which bind A . In this issue of PNAS, Robert Messing and colleagues (1) report a finding that suggests a new strategy for stimulating the enzymatic breakdown of A , which could produce benefit in AD. This strategy is based on the enzyme PKC, a serine threonine kinase that catalyzes the calciumand phospholipiddependent phosphorylation of protein substrates and is also a receptor for phorbol esters. Messing and colleagues (1) have been studying PKC for many years, especially the neurological effects of PKC isozymes. For example, one recent study (2) implicated neutrophil PKC in reperfusion injury after experimental stroke, consistent with work from Mochly-Rosen and colleagues (3) showing that a PKC inhibitor reduced infarct size. The present study (1) builds on previous findings that phorbol esters reduce A levels and the number of amyloid plaques in AD-transgenic mice (4) and that PKC decreases A levels in cell culture (5). These and other threads that link PKC and A are discussed in a recent review (6). Messing and colleagues (1) crossed two lines of transgenic mice, one that overexpresses PKC in neurons and another that expresses a mutant form of APP (the Indiana or V717F mutation) found in some patients with the rare familial form of AD. The latter mice exhibit some features of clinical AD, including the age-dependent deposition of extracellular amyloid plaques in selected brain regions. Plaque density, astrogliosis, and alterations in neurites were reduced in PKC -transgenic APPV717F compared with APPV717F mutant mice. Similar findings were obtained with other PKC and APP transgenics. Contrary to expectations, however, A synthesis was unaffected by PKC overexpression. Instead, PKC seemed to act by stimulating the degradation of A . A is a substrate for several enzymes, including insulin-degrading enzyme and neprilysin, the activities of which were unaltered in PKC transgenics. However, the activity of another A degrading enzyme, endothelin-converting enzyme (ECE) (7), was increased in hippocampus and cerebral neocortex of these mice. Previous cell-culture studies suggested that the effect of phorbol esters on ECE expression was mediated through the transcription factor Ets-1. Messing and colleagues (1) concluded that amyloid deposition was decreased in PKC -overexpressing mice because of increased ECE-mediated breakdown of A (Fig. 1). On the other hand, amyloid plaques were not increased in APPV717F PKC -null mice, presumably because of the redundancy of A degrading enzyme systems. As its name implies, ECE is involved in the processing not only of A but also of endothelins (ETs), a family of 21-aa peptides with potent vasoconstrictor action (8). These peptides are structurally and functionally related to sarafotoxins isolated from the venom of the burrowing asp, Atractaspis engaddensis. ET-1 was first isolated from porcine aortic endothelial cell cultures and shown to constrict blood vessels with picomolar affinity. ET-2 and ET-3 have subsequently been identified, as have two G protein-coupled receptors, ETA and ETB. ET-1 and its receptors are expressed on cerebral neurons, glia, and blood vessels, with highest brain ET-1 levels in cerebral cortex, striatum, hippocampus, and hypothalamus. The ETs are synthesized from pre-pro-ETs, which are cleaved by a furin-like endopeptidase to form big ETs, and then by either of three ECE isozyme families (ECE-1, ECE-2, or ECE-3) to generate mature ET peptides (9). Alternative synthetic pathways seem to exist in some cells. Like ETs and ET receptors, ECEs are associated with neurons as well as endothelial cells. ECE-1 hydrolyzes not only ETs (and A , as discussed above), but also bradykinin, substance P, angiotensin, and insulin. Alterations in ET signaling have been implicated in a variety of pathological conditions, including systemic hypertension, cerebral vasospasm after aneurysmal subarachnoid hemorrhage, atherosclerosis, myocardial infarction, congestive heart failure, pulmonary hypertension, chronic airway inflammation, and chronic renal failure (8). For this reason, there has been considerable interest in the ET system as a therapeutic target. For example, a variety of ECE inhibitors and ET receptor antagonists have been developed as potential treatments for some of the conditions listed above (9, 10).
منابع مشابه
Saudi Arabia’s Aggressive Oil Policy against Iran (2011-2016)
Iran and Saudi Arabia have long been engaged in heated rivalry and conflict in the Middle East. These two regional powers are both major oil-exporting countries; in major foreign policy issues, therefore, oil is used as an important tool to pursue goals. Iran and Saudi Arabia have a long history of differences on oil policies, but one of the most severe differences emerged in 2011-2016, along w...
متن کاملScreening seven Iranian medicinal plants for protective effects against β-Amyloid-induced cytotoxicity in cultured cerebellar granule neurons
Background and objectives: Alzheimer's disease (AD) as a neurodegenerative disorder is the most common form of dementia in the elderly. According to the amyloid hypothesis, accumulation of amyloid beta (Aβ) plaques, which are mostly constituted of Aβ peptide aggregates, triggers pathological cascades that lead to neuronal cell death. Thus, modulation of Aβ toxicity is the hopef...
متن کاملCrude Extract from Ziziphus Jujuba Fruits, a Weapon against Pediatric Infectious Disease
Abstract Background Pediatric infectious disease is one of the main problems in cancerous children that treat by chemotherapy drugs. Thus, study in this regard is necessary. The aim of this study was to evaluate antimicrobial properties of ethanolic extract of Ziziphus Jujuba fruits against different infectious pathogens. Materials and Methods This study is descriptive. In vitro antimicro...
متن کاملGlycogen synthase kinase-3β may contribute to neuroprotective effects of Sargassum oligocystum against amyloid-beta in neuronal SH-SY5Y cells
Glycogen synthase kinase (GSK)-3β mediates amyloid-beta (Aβ) and oxidative stress-induced neurotoxicity in neurodegenerative disorders. Natural products with antioxidant activity, such as Sargassum (S.) oligocystum may modulate GSK-3β enzyme and protect against Aβ-induced neurotoxicity. Therefore, we aimed to assess the neuroprotective effects of a methanolic extract of S. oligocystum against A...
متن کاملIslet Amyloid Polypeptide is not a Target Antigen for CD8+ T-Cells in Type 2 Diabetes
Background: Type 2 diabetes (T2D) is a chronic metabolic disorder in which beta-cells are destroyed. The islet amyloid polypeptide (IAPP) produced by beta-cells has been reported to influence beta-cell destruction. Objective: To evaluate if IAPP can act as an autoantigen and therefore, to see if CD8 + T-cells specific for this protein might be present in T2D patients. Methods: Peripheral blood ...
متن کاملKisspeptin-13 Improves Spatial Memory Consolidation and Retrieval against Amyloid-β Pathology
It has been shown that brain glucose metabolism impairment, obesity, and diabetes couldlead to cognitive decline and Alzheimer’s disease (AD) pathogenesis. Kisspeptin (KP) a G-proteincoupled receptor neuropeptide, has been suggested as a link between energy balance andreproduction. Some studies have shown that the attenuation of KP signaling decreases metabolismand energ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Proceedings of the National Academy of Sciences of the United States of America
دوره 103 21 شماره
صفحات -
تاریخ انتشار 2006